Creighton University

Research output

Research output per year 1958 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

• 7086 Article
• 1035 Review article
• 444 Chapter
• 291 Letter
• 701 More
  • 261 Comment/debate
  • 183 Editorial
  • 105 Conference contribution
  • 51 Short survey
  • 48 Book
  • 20 Foreword/postscript
  • 20 Patent
  • 10 Conference article
  • 3 Paper

Research output per year

Research output per year

Search results

• 2007

  Borrelia infections

  Knoop, F. C., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-4 4 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Borrelia Infections 100%

• Brill-zinsser disease

  Knoop, F. C., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-3 3 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Epidemic Louse-Borne Typhus 100%
  • Phthiraptera 92%
  • Epidemics 55%
  • Disease Progression 51%

• Calcitonin gene-related peptide

  Abel, P. & Smith, D. D., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-4 4 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Calcitonin Gene-Related Peptide 100%
  • Amino Acids 59%
  • Calcitonin 48%
  • Peptides 27%
  • Islet Amyloid Polypeptide 19%

• Cerebral ischemia

  Bruce, L., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-5 5 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

• Chronic fatigue syndrome

  Dickerson, D., Marcil, W. & Petty, F., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-5 5 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Chronic Fatigue Syndrome 100%
  • Fatigue 65%
  • Disease Outbreaks 34%
  • Neurasthenia 32%
  • Psychology 13%

• Compound 1

  Abel, P. & Taylor, C. K., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-4 4 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • 4-(2-oxo-2,3-dihydrobenzimidazol-1-yl)piperidine-1-carboxylic acid (1-(3,5-dibromo-4-hydroxybenzyl)-2-oxo-2-(4-phenylpiperazin-1-yl)ethyl)amide 100%
  • Calcitonin Gene-Related Peptide Receptor Antagonists 64%
  • Calcitonin Gene-Related Peptide 48%
  • Peptides 26%

• Corynebacterium infections

  Cavalieri, S. J. & Knoop, F. C., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-5 5 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Corynebacterium Infections 100%
  • Corynebacterium 76%
  • Corynebacterium diphtheriae 22%
  • Diphtheria 18%
  • Gram's stain 17%
  2 Scopus citations

• Coxsackievirus infections and NOD mice: Relevant models of protection from, and induction of, type 1 diabetes

  Tracy, S. & Drescher, K. M., Apr 2007, How Do We Best Employ Animal Models for Type 1 Diabetesand Multiple Sclerosis. Blackwell Publishing Inc., p. 143-151 9 p. (Annals of the New York Academy of Sciences; vol. 1103).

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Coxsackievirus Infections 100%
  • Mouse 90%
  • Diabetes 87%
  • Inbred NOD Mouse 82%
  • Induction 75%
  36 Scopus citations

• Disease caused by treponema pallidum, nonvenereal treponematoses, and leptospira

  Knoop, F. C., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-4 4 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Leptospira 100%
  • Treponema pallidum 97%
  • Pinta 45%
  • Treponemal Infections 43%
  • Yaws 35%

• Diseases caused by spirochetes

  Knoop, F. C., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-3 3 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Spirochaetaceae 100%
  • Spirochaetales 64%

• Drug induced neutropenia

  Boison, D., Patel, D. & Silberstein, P., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-3 3 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Neutropenia 100%
  • Leukocytes 79%
  • Neutrophils 78%
  • Inflammation 58%
  • Infections 47%
  1 Scopus citations

• Dystonias

  Kincaid, A., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-5 5 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Dystonia 100%
  • Muscles 21%
  • Focal Task-Specific Dystonia 19%
  • Movement Disorders 13%
  • Dyskinesias 13%
  1 Scopus citations

• Endogenous depression

  Wilson, D., Marcil, W. & Petty, F., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-7 7 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Depressive Disorder 100%
  • Depression 63%
  • Drug Therapy 56%

• Essential tremor

  Kincaid, A., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-4 4 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Essential Tremor 100%
  • Tremor 79%
  • Movement Disorders 20%
  • Sleep 14%
  • Alcohols 13%

• Establishment of a model to examine the early events involved in the development of virus-induced demyelinating lesions

  Drescher, K. M. & Tracy, S., Apr 2007, How Do We Best Employ Animal Models for Type 1 Diabetesand Multiple Sclerosis. Blackwell Publishing Inc., p. 152-156 5 p. (Annals of the New York Academy of Sciences; vol. 1103).

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Cord 100%
  • Demyelinating Diseases 85%
  • Virus 81%
  • Lesion 76%
  • Theilovirus 61%
  2 Scopus citations

• Evolution of the nervous system in reptiles

  Bruce, L. L., Jan 1 2007, Non-Mammalian Vertebrates. Elsevier Inc., Vol. 2. p. 125-156 32 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Reptiles 100%
  • Amphibians 88%
  • nervous system 77%
  • reptiles 73%
  • amphibians 66%
  30 Scopus citations

• Experienced Practice in Neurologic Rehabilitation: Experts in the Making

  Jensen, G. & Shepard, K., Dec 1 2007, Expertise in Physical Therapy Practice. Elsevier Inc., p. 107-124 18 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

• Expert Practice in Orthopedics: Competence, Collaboration, and Compassion

  Jensen, G. M., 2007, Expertise in Physical Therapy Practice. Elsevier Inc., p. 125-144 20 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter
  1 Scopus citations

• Fusospirochetal infections

  Knoop, F. C., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-3 3 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Necrotizing Ulcerative Gingivitis 100%
  • Fusobacterium 86%
  • Oropharynx 71%
  • Respiratory System 55%
  • Genitalia 54%

• Gonococcal infections

  Knoop, F. C., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-4 4 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Neisseria 100%
  • Physicians 45%
  • Infections 34%

• Haemophilus infections

  Knoop, F. C., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-4 4 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Haemophilus Infections 100%
  • Haemophilus 95%
  • Names 64%

• Hallucinogen abuse

  Warsi, M., Marcil, W. & Petty, F., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-7 7 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Hallucinogens 100%
  • Diagnostic and Statistical Manual of Mental Disorders 67%
  • Cognition 28%

• Hemophilia

  Schrader, J., White, M. & Silberstein, P., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-4 4 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Hemophilia A 100%
  • Hemorrhage 57%
  1 Scopus citations

• Heparin induced thrombocytopenia

  Jones, D. & Silberstein, P., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-4 4 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Thrombocytopenia 100%
  • Heparin 96%

• Human alphaCGRP-8-37

  Abel, P. & Taylor, C. K., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-6 6 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • calcitonin gene-related peptide (8-37) 100%
  • Calcitonin Gene-Related Peptide 75%
  • Amino Acids 45%
  • Peptides 41%

• Hyperkalemia

  Abel, P., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-4 4 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Hyperkalemia 100%
  • Potassium 72%
  • Electrolytes 39%
  • Osmotic Pressure 24%
  • Extracellular Space 22%
  1 Scopus citations

• Idiopathic thrombocytopenic purpura

  Silberstein, P., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-4 4 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Idiopathic Thrombocytopenic Purpura 100%
  • Platelet Count 40%
  • Blood Platelets 32%

• Infections due to campylobacter

  Schrank, G. D. & Knoop, F. C., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-4 4 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Campylobacter 100%
  • Bacillus 77%
  • Infections 37%

• Inflammatory myopathies

  Bockman, C. S. & Eckerson, J., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-7 7 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Myositis 100%
  • Connective Tissue Diseases 98%
  • Immune System Diseases 87%
  • Muscle Weakness 87%
  • Skeletal Muscle 65%

• Influenza a

  Huggett, K. D. & Knoop, F. C., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-7 7 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Orthomyxoviridae 100%
  • Human Influenza 91%
  • RNA 68%

• Iron deficiency anemia

  Caracioni, A. A., Wahl, A., Walsh, S. & Silberstein, P., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-4 4 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Iron-Deficiency Anemias 100%
  • Anemia 71%
  • Erythrocytes 66%
  2 Scopus citations

• Isoproterenol

  Abel, P. & Rorabaugh, B., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-7 7 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Isoproterenol 100%
  • Adrenergic Receptors 46%
  1 Scopus citations

• Klebsiella infections

  Knoop, F. C., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-4 4 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Klebsiella Infections 100%
  • Klebsiella 77%
  • Enterobacteriaceae 72%
  • Bacillus 64%

• Manic-depressive illness

  Fernandes, P. P., Ramaswamy, S., Marcil, W. & Petty, F., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-6 6 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Major Affective Disorder 2 100%
  • Bipolar Disorder 61%

• Melanoma

  Hansen, L., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-4 4 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Melanoma 100%
  • Ultraviolet Rays 41%
  • Secondary Prevention 39%
  • Skin 22%
  • Neoplasms 12%

• Meningitis

  Sandstrom, R., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-4 4 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Meningitis 100%
  • Communicable Diseases 85%
  • Membranes 59%
  • Inflammation 58%

• Methemoglobinemia

  Kutayli, W. M. & Silberstein, P., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-5 5 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter
  2 Scopus citations

• Mood disorders

  Khan, S. S., Marcil, W. & Petty, F., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-9 9 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Color Perception 100%
  • Mood Disorders 63%
  • Emotions 51%

• Moraxella infections

  Knoop, F. C., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-4 4 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Moraxellaceae Infections 100%
  • Moraxella 81%
  • Moraxella catarrhalis 68%
  • Respiratory System 48%
  • Oxidoreductases 46%

• Murine (endemic) typhus

  Knoop, F. C., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-3 3 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Endemic Flea-Borne Typhus 100%
  • Rickettsia typhi 52%
  • Rickettsia Infections 45%
  • Siphonaptera 44%
  • Kuwait 41%

• Muscular dystrophy

  Kincaid, A., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-6 6 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Muscular Dystrophies 100%
  • Muscle Weakness 44%
  • Age of Onset 39%
  • Skeletal Muscle 33%
  • Muscles 25%
  1 Scopus citations

• Myalgia

  Bockman, C. S. & Eckerson, J., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-7 7 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Myalgia 100%

• Myasthenia gravis

  Kincaid, A., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-5 5 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Myasthenia Gravis 100%
  • Neuromuscular Junction Diseases 68%
  • Antibodies 47%
  • Nicotinic Receptors 47%
  • Muscle Weakness 45%

• Mycosis fungoides

  Hansen, L., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-4 4 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Mycosis Fungoides 100%
  • Skin 42%

• Nicotine and associated chemicals abuse

  Wilson, D., Padala, P., Ramaswamy, S. & Petty, F., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-5 5 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

• Obsessive compulsive disorders

  Faramazyan, A. Y., Marcil, W. & Petty, F., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-7 7 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Obsessive-Compulsive Disorder 100%
  • Thinking 88%

• Opioid abuse

  Sharma, A., Marcil, W. & Petty, F., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-6 6 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Opioid-Related Disorders 100%
  • Peptides 52%

• Peripheral neuropathies

  Sandstrom, R., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-5 5 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Sensation Disorders 100%
  • Peripheral Nervous System Diseases 71%

• Pernicious anemia

  Duthuluru, S. & Silberstein, P., Jan 1 2007, xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., p. 1-4 4 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Pernicious Anemia 100%
  • Gastritis 77%
  • H(+)-K(+)-Exchanging ATPase 57%
  • Megaloblastic Anemia 26%
  • Thymectomy 23%

• Pharmacodynamics and antibacterial resistance

  Lister, P. D., Hanson, N. D. & Ehrhardt, A. F., Jun 15 2007, Antimicrobial Pharmacodynamics in Theory and Clinical Practice, Second Edition. CRC Press, p. 463-485 23 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter